checkAd

     559  0 Kommentare Research and Markets - Cell-Free DNA Market Size and Share Analysis to 2021 with Profiles of Agilent Technologies, Bio-Rad, F. Hoffmann-La Roche, Fluidigm, Illumina, Qiagen, RainDance Technologies & Thermo Fisher Scientific - Seite 2



    Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services.

    The report profiles those companies competing in the cfDNA instruments and consumables market, including:

    - Agilent Technologies
    - Bio-Rad
    - F. Hoffmann-La Roche AG
    - Fluidigm
    - Illumina
    - Qiagen
    - RainDance Technologies
    - Thermo Fisher Scientific

    The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

    Key Topics Covered:

    1: Executive Summary

    - NIPT, Oncology Leading Market Forward
    - Sensitivity Benefits of dPCR, qPCR, NGS
    - Challenges, Biological and Technologies Limitations
    - Scope and Methodology

    2: Introduction

    - NIPT Companies, Others Shifting Strategies to Cancer
    - Expanding Clinical Adoption Sustains High Growth
    - Government Initiatives - Cancer Moonshot, Blood Profiling Atlas
    - Mergers, Acquisitions, Equity Investments Increasing
    - China Becoming Major Player in Market
    - Personalized, Proactive Medicine Gaining Momentum
    - Expected Sequencer Platforms Stalled or Cancelled
    - Significant Efforts in Automation, Miniaturization
    - Regulatory Situation Unclear But Evolving Somewhat

    3: CFDNA PRODUCTS

    - cfDNA Reagents, Consumables, and Kits
    - cfDNA Systems and Software
    - cfDNA NIPT Products and Services
    - cfDNA in Oncology, Transplantation and Other Diseases
    - cfDNA Other Products
    - Recent Product/ Service Introductions

    4: Market Size And Share Analysis

    - Revenues Forecast
    - Market Size and Forecast
    - cfDNA Clinical Diagnostics Market
    - cfDNA Market by Region
    - Revenues by Product Type
    - Illumina Sequencing Revenues as Indicator

    5: Corporate Profiles

    - Agilent Technologies
    - F. Hoffmann-La Roche AG
    - Fluidigm
    - Illumina
    - Qiagen
    - RainDance Technologies
    - Thermo Fisher Scientific

    6: Challenges and Strategic Recommendations

    - Challenges
    - Strategic Recommendations
    - List of Exhibits

    7: cfDNA Analysis Products

    8: Market Analysis

    9: cfDNA Analysis Market Deals

    For more information about this report visit http://www.researchandmarkets.com/research/xctpgm/cellfree_dna


    Media Contact:


    Research and Markets
    Laura Wood, Senior Manager
    press@researchandmarkets.com

    For E.S.T Office Hours Call +1-917-300-0470
    For U.S./CAN Toll Free Call +1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716

     



    Seite 2 von 2




    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Research and Markets - Cell-Free DNA Market Size and Share Analysis to 2021 with Profiles of Agilent Technologies, Bio-Rad, F. Hoffmann-La Roche, Fluidigm, Illumina, Qiagen, RainDance Technologies & Thermo Fisher Scientific - Seite 2 DUBLIN, May 22, 2017 /PRNewswire/ - Research and Markets has announced the addition of the "Cell-Free DNA (cfDNA): Market Size and Share Analysis" report to their offering. The use of cell-free DNA (cfDNA) and liquid biopsies of other analytes has …